Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Calamos Advisors
Quarter-by-quarter ownership of Alnylam Pharmaceuticals Inc Note 1.000 9/1 shares owned by Calamos Advisors
from 13F filings
Historical chart of Calamos Advisors investment in Alnylam Pharmaceuticals Inc Note 1.000 9/1
Tip: Access up to 7 years of quarterly data
All positions including Alnylam Pharmaceuticals Inc Note 1.000 9/1 held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Alnylam Pharmaceuticals Inc Note 1.000 9/1 by Calamos Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $602k | 365k | 1.65 |
| 2025-06-30 | $54M | 41M | 1.30 |
| 2025-03-31 | $48M | 41M | 1.15 |
| 2024-12-31 | $44M | 41M | 1.07 |
| 2024-09-30 | $60M | 51M | 1.17 |
| 2024-06-30 | $51M | 47M | 1.08 |
| 2024-03-31 | $44M | 47M | 0.94 |
| 2023-12-31 | $56M | 56M | 0.99 |
| 2023-09-30 | $52M | 56M | 0.93 |
Top funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1
View all funds holding Alnylam Pharmaceuticals Inc Note 1.000 9/1